News
Vertex Pharmaceuticals' new therapy, zimislecel, has potential to be a "functional cure," experts say. To continue reading ...
Medtronic (NYSE:MDT) announced today that it received CE mark to expand its MiniMed 780G's indications, including for type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback